Insight Molecular Diagnostics Inc. Segment Reporting Other Item Amount
Insight Molecular Diagnostics Inc. (IMDX) reported Segment Reporting Other Item Amount of $52.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Segment Reporting
us-gaap:SegmentReportingOtherItemAmount · last filed 2026-08-10
- Insight Molecular Diagnostics Inc. segment reporting other item amount for the quarter ending 2026-06-30 was $52.00K, a 11.86% decline year-over-year.
- Insight Molecular Diagnostics Inc. segment reporting other item amount for the quarter ending 2026-03-31 was $109.00K, a 37.71% decline year-over-year.
- Insight Molecular Diagnostics Inc. segment reporting other item amount for the quarter ending 2025-12-31 was $485.00K.
- Insight Molecular Diagnostics Inc. segment reporting other item amount for the quarter ending 2025-09-30 was -$97.00K.
- Insight Molecular Diagnostics Inc. segment reporting other item amount for fiscal 2025 was $633.00K, a 681.48% increase from fiscal 2024.
- Insight Molecular Diagnostics Inc. segment reporting other item amount for fiscal 2024 was $81.00K, a 92.30% decline from fiscal 2023.
- Insight Molecular Diagnostics Inc. segment reporting other item amount for fiscal 2023 was $1.05M.
| Period end | Segment Reporting Other Item Amount 3 month | Segment Reporting Other Item Amount 3 month as first filed | Segment Reporting Other Item Amount 6 month | Segment Reporting Other Item Amount 6 month as first filed | Segment Reporting Other Item Amount 9 month | Segment Reporting Other Item Amount 12 month | Segment Reporting Other Item Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $52.00K 10-Q · filed 2026-08-10 | $161.00K 10-Q · filed 2026-08-10 | $646.00K derived: sum of 3 quarters · filed 2026-08-10 | $549.00K derived: sum of 4 quarters · filed 2026-08-10 | |||
| 2026-03-31 | $109.00K 10-Q · filed 2026-05-13 | $594.00K derived: sum of 2 quarters · filed 2026-05-13 | $497.00K derived: sum of 3 quarters · filed 2026-05-13 | $556.00K derived: sum of 4 quarters · filed 2026-08-10 | |||
| 2025-12-31 | $485.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $388.00K derived: sum of 2 quarters · filed 2026-03-26 | $447.00K derived: sum of 3 quarters · filed 2026-08-10 | $633.00K 10-K · filed 2026-03-26 | |||
| 2025-09-30 | -$97.00K 10-Q · filed 2025-11-10 | -$38.00K derived: sum of 2 quarters · filed 2026-08-10 | $148.00K 10-Q · filed 2025-11-10 | $88.00K derived: sum of 4 quarters · filed 2026-08-10 | |||
| 2025-06-30 | $59.00K 10-Q · filed 2026-08-10 | $66.00K 10-Q · filed 2025-08-11 | $234.00K 10-Q · filed 2026-08-10 | $246.00K 10-Q · filed 2025-08-11 | $185.00K derived: sum of 3 quarters · filed 2026-08-10 | $184.00K derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-03-31 | $175.00K 10-Q · filed 2026-05-13 | $375.00K 10-Q · filed 2025-05-12 | $126.00K derived: sum of 2 quarters · filed 2026-05-13 | $125.00K derived: sum of 3 quarters · filed 2026-05-13 | $169.00K derived: sum of 4 quarters · filed 2026-05-13 | ||
| 2024-12-31 | -$49.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$50.00K derived: sum of 2 quarters · filed 2026-03-26 | -$6.00K derived: sum of 3 quarters · filed 2026-03-26 | $81.00K 10-K · filed 2026-03-26 | $666.00K 10-K · filed 2025-03-24 | ||
| 2024-09-30 | -$1.00K 10-Q · filed 2025-11-10 | $43.00K derived: sum of 2 quarters · filed 2025-11-10 | $130.00K 10-Q · filed 2025-11-10 | ||||
| 2024-06-30 | $44.00K 10-Q · filed 2025-08-11 | $131.00K 10-Q · filed 2025-08-11 | |||||
| 2024-03-31 | $158.00K 10-Q · filed 2025-05-12 | ||||||
| 2023-12-31 | $1.05M 10-K · filed 2025-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |